GeneFab

GeneFab is approaching our 1 year anniversary, and we thank all of our clients and employees that helped us be very successful in our first year. GeneFab is officially on the map helping the innovative Cell Therapy innovators. We are drug manufacturers that are drug makers, having spent 7 years as a biotech developing innovative drugs. Now we have already signed multiple clients, and you can access this team to advance your programs. GeneFab is the genetic and synthetic engineering company focused on outsourced R&D for drug design (synthetic biology foundry) as well as manufacturing of Cell Therapies (all types). - Synthetic Biology Design Services: https://lnkd.in/gbuwjET8 - Cell Therapy Platforms: https://lnkd.in/gNQZxYZj - End-to-end Clinical and Commercial manufacturing including Cell Banking, Viral Vector (Gamma Retro, Lentivirus, others), and Rapid Tech Transfer to cGMP manufacturing: https://lnkd.in/gufrhgfj

As the leading manufacturer of NK Cell Therapies we are always pleased to read and share work to target diseases done by colleagues around the globe. This one comes from Southern California. https://lnkd.in/gCDiHH-S GeneFab is the genetic and synthetic engineering company focused on outsourced R&D for drug design (synthetic biology foundry) as well as manufacturing of Cell Therapies (all types). Synthetic Biology Design Services: https://lnkd.in/gbuwjET8 Cell Therapy Platforms: https://lnkd.in/gNQZxYZj All Services for end-to-end Clinical and Commercial manufacturing including Cell Banking, Viral Vector (Gamma Retro, Lentivirus, others), and Rapid Tech Transfer to manufacturing: https://lnkd.in/gufrhgfj

A personal congratulations to Senti and CIRM from GeneFab's CEO Philip Lee: "Congrats Senti and CIRM! This is an excellent example of how breakthrough innovation in cell therapies can be directly accelerated by CIRM to impact patients and strengthen California biotech."

We're #hiring a new QC Analyst I in Alameda, California. Apply today or share this post with your network.

Congrats to our partners Senti Biosciences on the commencement of their Phase 1 clinical trial! Proud to be collaborating with you on manufacturing SENTI-202, a potential cell therapy for treating relapsed/refractory hematologic malignancies including acute myeloid leukemia (AML). #syntheticbiology

Join us at #ASGCT24 for our second presentation where we’ll be showcasing the development of highly potent promoters that activate gene expression specifically in macrophages in the anti-inflammatory state to enable control of macrophage phenotype. Looking forward to seeing you there or at Booth #1641!

Join us today at #ASGCT24 for a presentation where we’ll be highlighting a novel method for regulating gene expression using FDA-approved small molecules that pass the blood brain barrier. If you can’t make the poster presentation, come by Booth #1641 to learn more. 

Exciting start at the GeneFab booth at #ASGCT24 today! We are thrilled to be here showcasing our cutting-edge CRDMO solutions. Swing by Booth #1641 this week to meet our team and explore how we can accelerate your #cellandgenetherapy journey. Don't miss out on our engaging mini seminars led by our #SynBio experts and GMP Technical leads. Let's shape the future of #therapeutics together! 

GeneFab is gearing up for an exciting week of innovation and collaboration demonstrating our synthetic biology and manufacturing expertise at the American Society of Gene & Cell Therapy’s 27th Annual Meeting. Join us at Booth #1641 to connect with our team of executives, BD leaders, scientists, and GMP Technical leads. Discover how we can accelerate your #cellandgenetherapy journey together. Plus, don't miss our daily mini seminars hosted by our talented #syntheticbiology scientists and GMP Technical Development team! See you there! #ASGCT24

The American Society of Gene & Cell Therapy's 27th Annual Meeting is just around the corner! Don't forget to mark your calendars for May 7-11 and visit GeneFab at Booth #1641. Have you signed up for 1:1 time at our booth with GeneFab scientists and business development leaders? Don't miss this opportunity to discuss how we can accelerate your journey in drug development and CMC. Contact us today to reserve your slot! https://bit.ly/4dlZZR2 #ASGCT24